We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Thermo Fisher Scientific
TMO
$211B
| $7.97M | 0.03% |
29,120
+674
| +2% | +$168K |
|
|
AMRN
202
Amarin Corp
AMRN
$284M
| $7.89M | 0.03% |
19,005
+17,419
| +1,098% | +$6.28M |
|
203
Norfolk Southern
NSC
$78.8B
| $7.85M | 0.03% |
42,024
+1,972
| +5% | +$341K |
|
204
Commerce Bancshares
CBSH
$8.5B
| $7.83M | 0.03% |
189,695
+3,565
| +2% | +$153K |
|
205
Royal Bank of Canada
RY
$291B
| $7.77M | 0.03% |
102,902
+1,566
| +2% | +$118K |
|
206
CryoPort
CYRX
$775M
| $7.73M | 0.03% |
598,475
-11,544
| -2% | -$125K |
|
207
PayPal
PYPL
$49.5B
| $7.72M | 0.03% |
74,375
+5,343
| +8% | +$506K |
|
208
CVS Health
CVS
$137B
| $7.72M | 0.03% |
143,181
+3,490
| +2% | +$215K |
|
209
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $7.63M | 0.03% |
64,115
-6,076
| -9% | -$704K |
|
210
Yum China
YUMC
$14.9B
| $7.61M | 0.03% |
169,346
-2,853
| -2% | -$112K |
|
211
iShares International Developed Real Estate ETF
IFGL
$81.6M
| $7.49M | 0.03% |
246,278
+1,779
| +0.7% | +$52K |
|
|
MORL
212
DELISTED
ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN
MORL
| $7.3M | 0.03% |
483,150
-3,994
| -0.8% | -$57.7K |
|
|
SAVE
213
DELISTED
Spirit Airlines, Inc.
SAVE
| $7.26M | 0.03% |
137,369
+7,815
| +6% | +$450K |
|
214
American Electric Power
AEP
$73.7B
| $7.25M | 0.03% |
86,541
+10,844
| +14% | +$862K |
|
215
iShares Core S&P Total US Stock Market ETF
ITOT
$93.2B
| $7.24M | 0.03% |
112,488
+10,652
| +10% | +$661K |
|
216
Paychex
PAYX
$40.4B
| $6.9M | 0.02% |
86,078
+853
| +1% | +$62.9K |
|
217
Loop Industries
LOOP
$38.9M
| $6.87M | 0.02% |
867,570
+35,000
| +4% | +$335K |
|
218
Biogen
BIIB
$29.9B
| $6.83M | 0.02% |
28,883
+1,867
| +7% | +$588K |
|
219
Novartis
NVS
$295B
| $6.72M | 0.02% |
78,056
-3,158
| -4% | -$254K |
|
220
Deere & Co
DE
$170B
| $6.71M | 0.02% |
41,995
-802
| -2% | -$128K |
|
221
Brookfield
BN
$102B
| $6.67M | 0.02% |
400,516
+99,940
| +33% | +$1.56M |
|
222
iShares S&P 500 Value ETF
IVE
$48.9B
| $6.65M | 0.02% |
59,013
+951
| +2% | +$104K |
|
223
Baidu
BIDU
$35.8B
| $6.62M | 0.02% |
40,169
+4,415
| +12% | +$739K |
|
224
FedEx
FDX
$74.5B
| $6.57M | 0.02% |
36,228
+755
| +2% | +$133K |
|
225
American Tower
AMT
$77.7B
| $6.52M | 0.02% |
33,102
+843
| +3% | +$148K |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.